RIGHTEST iFree2 CGM

RIGHTEST iFree2 CGM

Blood Glucose Monitors

Information

RIGHTEST iFree2 CGM — Designed for Trust, Sustainability, and Ease of Use Bionime proudly offers the RIGHTEST iFree2 CGM, a reliable and competitive continuous glucose monitoring system that delivers 15 days of real-time, minute-by-minute glucose data. This wearable device empowers users to manage diabetes with enhanced confidence, clarity, and control. With mobile connectivity, real-time alerts, and a lightweight design, the iFree2 CGM makes glucose monitoring simpler and more sustainable than ever. Why Choose iFree2 CGM? 🔹 Up to 15 Days of Continuous Wear iFree2 CGM measures glucose every minute and transmits data directly to the iFree CGM App—offering continuous insight without routine finger pricks. 🔹 Real-Time Alerts Get instant notifications for high and low glucose levels—helping users take prompt action and stay in control. 🔹 Lifestyle Insights & Time in Range (TIR) Track glucose patterns, monitor trends, and fine-tune your lifestyle to improve TIR. 🔹 Flexible Calibration The iFree2 CGM is factory-calibrated, with optional calibration support. 🔹 Stay Connected, Stay Supported Seamlessly share glucose data via the RIGHTEST Partner App with healthcare providers, caregivers, and family—building a supportive circle for better outcomes.
Bionime CorporationS7.A99About Bionime Founded in 2003, Bionime is a global innovator in blood glucose management. We specialize in the research, design, manufacturing, and marketing of advanced solutions for personal and professional diabetes care, including Blood Glucose Meters (BGM), Continuous Glucose Monitoring systems (CGM), and Point-of-Care Testing (POCT). iFree2 CGM Bionime proudly presents the iFree2 CGM, a reliable and competitive Continuous Glucose Monitoring solution engineered for accuracy, sustainability, and user comfort. With up to 15 days of real-time glucose data, smart alerts, and an intuitive design, iFree2 CGM transforms glucose monitoring into a simpler and smarter experience. RIGHTEST Diabetes Care Ecosystem Under our proprietary RIGHTEST brand, Bionime delivers a cloud-based blood glucose management ecosystem powered by IoT digital solutions. By integrating product-generated medical data with customer service and market insights, RIGHTEST enables a human-centered, connected diabetes care experience with real-time data for smarter decision-making. Global Presence Headquartered in Taiwan, Bionime has established subsidiaries across four continents and works closely with a global distributor network spanning nearly 100 countries. Together, we deliver localized support and comprehensive solutions to meet the evolving needs of diabetes care worldwide.

Log in

See all the content and easy-to-use features by logging in or registering!